TAIM
GILD icon

Te Ahumairangi Investment Management’s Gilead Sciences GILD Stock Holding History

Te Ahumairangi Investment Management’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$6.53M Sell
46,856
-5,120
-10% -$717K 1.09% 27
2025
Q4 		$6.38M Sell
51,976
-8,180
-14% -$994K 1.14% 25
2025
Q3 		$6.68M Buy
60,156
+780
+1% +$88.7K 1.13% 27
2025
Q2 		$6.58M Buy
59,376
+9,624
+19% +$1.02M 1.18% 26
2025
Q1 		$5.58M Sell
49,752
-6,869
-12% -$709K 1.18% 27
2024
Q4 		$5.23M Sell
56,621
-24,145
-30% -$2.17M 1.09% 29
2024
Q3 		$6.73M Sell
80,766
-9,587
-11% -$732K 1.19% 29
2024
Q2 		$6.2M Sell
90,353
-1,610
-2% -$107K 1.19% 30
2024
Q1 		$6.74M Buy
91,963
+3,290
+4% +$253K 1.17% 32
2023
Q4 		$7.18M Sell
88,673
-28,200
-24% -$2.19M 1.36% 24
2023
Q3 		$8.76M Sell
116,873
-12,200
-9% -$938K 1.42% 22
2023
Q2 		$9.95M Buy
129,073
+16,185
+14% +$1.29M 1.36% 22
2023
Q1 		$9.37M Buy
112,888
+8,541
+8% +$707K 1.34% 22
2022
Q4 		$8.96M Sell
104,347
-21,865
-17% -$1.73M 1.4% 23
2022
Q3 		$7.79M Sell
126,212
-24,145
-16% -$1.52M 1.32% 26
2022
Q2 		$9.29M Sell
150,357
-270
-0.2% -$16.7K 1.4% 23
2022
Q1 		$8.96M Buy
150,627
+14,620
+11% +$935K 1.22% 31
2021
Q4 		$9.88M Buy
136,007
+10,000
+8% +$689K 1.28% 27
2021
Q3 		$8.8M Sell
126,007
-4,000
-3% -$281K 1.21% 29
2021
Q2 		$8.95M Sell
130,007
-9,500
-7% -$634K 1.17% 31
2021
Q1 		$9.02M Buy
139,507
+29,000
+26% +$1.87M 1.16% 32
2020
Q4 		$6.44M Buy
110,507
+22,300
+25% +$1.35M 0.9% 44
2020
Q3 		$5.57M Buy
+88,207
New +$6.12M 0.95% 39

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Te Ahumairangi Investment Management's GILD Position: Q1 2026 in Review

Te Ahumairangi Investment Management reduced its Gilead Sciences (GILD) stake by 9.9% in Q1 2026, selling an estimated $717K and leaving 46,856 shares worth $6.53M. The position accounts for 1.09% of the portfolio, ranked #27.

Te Ahumairangi Investment Management first reported a position in GILD in Q3 2020 and has held it in 23 quarters since. The position peaked at $9.95M in Q2 2023. 2,316 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Te Ahumairangi Investment Management held 46,856 shares of Gilead Sciences worth $6.53M as of Q1 2026.
  • Te Ahumairangi Investment Management sold 5,120 Gilead Sciences shares in Q1 2026, an estimated $717K.
  • Gilead Sciences made up 1.09% of Te Ahumairangi Investment Management's portfolio in Q1 2026, its #27 holding.
  • Te Ahumairangi Investment Management first reported a position in Gilead Sciences in Q3 2020 and has held it in 23 quarters since.
  • Te Ahumairangi Investment Management's Gilead Sciences position peaked at $9.95M in Q2 2023.
  • 2,316 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Te Ahumairangi Investment Management's 13F filing for Q1 2026, filed 15 May 2026.